Company Profile

Apyx Medical Corporation (formerly known as Bovie® Medical Corporation) is an advanced energy technology company with a passion for elevating people’s lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium Plasma Technology, Apyx is solely focused on bringing transformative solutions to the physicians and patients it serves. The company’s Helium Plasma Technology is marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion offers plastic surgeons, fascial plastic surgeons and cosmetic physicians a unique ability to provide controlled heat to the tissue to achieve their desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. The Company also leverages its deep expertise and decades of experience in unique waveforms through original equipment manufacturing (OEM) agreements with other medical device manufacturers.

COMPANY ADDRESS

Apyx Medical Corporation
5115 Ulmerton Road • Clearwater, FL 33760-4004 • USA
Ph +1 727 384 2323

MANAGEMENT TEAM

Charles D. Goodwin, President and Chief Executive Officer | Bio
Tara Semb, Chief Financial Officer | Bio
Moshe Citronowicz, Senior Vice President | Bio
Todd Hornsby, Executive Vice President | Bio

BOARD OF DIRECTORS

Andrew Makrides, Esq., Executive Chairman of the Board of Directors | Bio
Charles D. Goodwin, Chief Executive Officer & Director | Bio
John Andres, Director | Bio
Michael Geraghty
, Director | Bio
Craig A. Swandal, Director | Bio
Lawrence J. Waldman, CPA, Director | Bio

Company Presentations

COMPANY INVESTOR PRESENTATION

FIRST QUARTER 2019
EARNINGS CALL

Management hosted a conference call on May 8 to discuss the results of the quarter and to host a question and answer session.  To listen to a replay of the webcast, click on the WEBCAST button below.

Company Events

UPCOMING EVENTS

Second Quarter 2019
Earnings Call

Management will host a conference call at 4:30 p.m. Eastern Time on August 7 to discuss the financial results for the second quarter of fiscal year 2019. To listen to the call by phone, interested parties may dial 844-507-6493 (or 647-253-8641 for international callers) and provide access code 5115769. Participants should ask for the Apyx Medical Corporation Call. A live webcast of the call will be accessible by clicking on the button below.

Top